Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.88 USD | 0.00% | -6.15% | -30.18% |
13/05 | HC Wainwright Adjusts Price Target on Verona Pharma to $30 From $32, Maintains Buy Rating | MT |
09/05 | Verona Pharma Signs Financing Agreements for Up to $650 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.18% | 1.12B | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- VRNA Stock
- News Verona Pharma plc
- Canaccord Genuity Adjusts Price Target on Verona Pharma to $23 From $18, Keeps Buy Rating